Document Detail


PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators.
MedLine Citation:
PMID:  19784964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The tumor suppressor PTEN regulates many biological processes. A well-known downstream effector of PTEN is phospho-Akt. Although PTEN is the most frequently inactivated gene in prostate cancer, its mode of action is not fully understood. We studied the association of regulated PTEN expression with changes in biological function and gene expression profiles. METHODS: PTEN-negative LNCaP cells were stably transfected with wild-type PTEN cDNA under inducible control, resulting in LNCaP/PTEN cells. Microarray analysis was used to monitor gene expression changes upon induction of PTEN. Expression of selected individual genes was studied in Q-PCR and siRNA experiments. Cell-cycle distribution was analyzed by flow cytometry. RESULTS: Induced expression of PTEN in LNCaP/PTEN cells significantly inhibited cell proliferation, at least partly due to cell-cycle arrest at the G1 phase. Expression profiling combined with pathway analysis revealed that PTEN-dependent G1 growth arrest was associated with an altered mRNA expression of the G1 cell-cycle regulators Cdc25a, E2F2, cyclin G2, and RBL2/p130. Specific inhibition of Akt signaling by siRNA resulted in downregulation of both E2F2 and Cdc25a mRNA expression and upregulation of the FOXO target cyclin G2, similar to the effect observed by PTEN induction. However, Akt did not mediate the PTEN-dependent RBL2/p130 mRNA expression in LNCaP/PTEN cells. CONCLUSIONS: The results indicate that PTEN dependent gene expression is important in cell-cycle regulation and is mediated by both Akt-dependent and -independent mechanisms.
Authors:
P W van Duijn; A C J Ziel-van der Made; J A G van der Korput; J Trapman
Related Documents :
23286224 - Post-transcriptional processing of genetic information and its relation to cancer.
6134754 - Adenosine deaminase messenger rnas in lymphoblast cell lines derived from leukemic pati...
19615744 - Significant inverse correlation of microrna-150/myb and microrna-222/p27 in myelodyspla...
23356564 - A winning smile? smile intensity, physical dominance, and fighter performance.
9008304 - Stimulation through cd50 (icam-3) induces both activation and programmed cell death of ...
16683234 - Auf-1 mediates inhibition by nitric oxide of lipopolysaccharide-induced matrix metallop...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Prostate     Volume:  70     ISSN:  1097-0045     ISO Abbreviation:  Prostate     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2009-12-28     Completed Date:  2010-01-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8101368     Medline TA:  Prostate     Country:  United States    
Other Details:
Languages:  eng     Pagination:  135-46     Citation Subset:  IM    
Affiliation:
Department of Pathology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Cycle / genetics*
Cell Cycle Proteins / genetics*
Cell Line, Tumor
Cell Proliferation
Gene Expression Profiling
Humans
Male
Oligonucleotide Array Sequence Analysis
PTEN Phosphohydrolase / genetics*
Prostatic Neoplasms / genetics*
Transfection
Chemical
Reg. No./Substance:
0/Cell Cycle Proteins; EC 3.1.3.48/PTEN protein, human; EC 3.1.3.67/PTEN Phosphohydrolase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of cross- or multiple resistance to the acetyl-coenzyme A carboxylase inhibitors fenoxapr...
Next Document:  Engineering a beta-Helical d,l-Peptide for Folding in Polar Media.